<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02851446</url>
  </required_header>
  <id_info>
    <org_study_id>FOIGNOT 2015</org_study_id>
    <nct_id>NCT02851446</nct_id>
  </id_info>
  <brief_title>Prevalence and Risk Factors of Reventilation Syndrome in a Population of Patients Under Ventilation for Whatever Reason</brief_title>
  <acronym>DEVENTILATION</acronym>
  <official_title>Prevalence and Risk Factors of Dreentilation Syndrome in a Population of Patients Under Ventilation for Whatever Reason</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <brief_summary>
    <textblock>
      Non-invasive nocturnal ventilation is an effective treatment for chronic respiratory failure,&#xD;
      whether due to obstructive (COPD), restrictive or neuromuscular causes, notably for patients&#xD;
      in the last two categories for whom it significantly prolongs life expectancy. Overall, the&#xD;
      treatment is well tolerated, its principal adverse effects being discomfort related to the&#xD;
      mask.&#xD;
&#xD;
      In certain patients, morning dyspnoea when the mask is removed has been described. This is&#xD;
      disabling as it limits everyday activities for at least 30 minutes, and defines deventilation&#xD;
      syndrome. The pathophysiology of this syndrome is uncertain, notably the roles of&#xD;
      hyperinflation, patient/ventilator asynchrony, or the sudden increase in diaphragmatic work&#xD;
      after a night of rest.&#xD;
&#xD;
      The aim of this study is to investigate the prevalence of and factors associated with&#xD;
      reventilation syndrome (DS) in a population of patients with ventilation whatever the reason,&#xD;
      in a stable state, and followed by the medical devices department of Dijon CHU, so as to&#xD;
      better understand the mechanisms. Patients with DS will subsequently be invited to&#xD;
      participate in a therapeutic trial.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2015</start_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>presence of diagnostic criteria for reventilation Syndrome (dyspnoea &gt; Borg 7)</measure>
    <time_frame>at withdrawal of the machine, disabling for everyday activities for at least 30 minutes after stopping the ventilation</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Prevalence of and Factors Associated With Reventilation Syndrome (DS)</condition>
  <arm_group>
    <arm_group_label>DS</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>no DS</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>measure dyspnoea&gt; Borg 7</intervention_name>
    <arm_group_label>DS</arm_group_label>
    <arm_group_label>no DS</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        population of patients with ventilation whatever the reason, in a stable state, and&#xD;
        followed by the medical devices department of Dijon CHU&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients over 18 years old&#xD;
&#xD;
          -  ventilation for whatever reason&#xD;
&#xD;
          -  in the ST mode&#xD;
&#xD;
          -  not in life support&#xD;
&#xD;
          -  at more than 1 month after the last episode of respiratory decompensation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  guardianship&#xD;
&#xD;
          -  inability to understand instructions and provide consent&#xD;
&#xD;
          -  uncontrolled psychiatric disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Clément FOIGNOT</last_name>
    <phone>03.80.29.37.72</phone>
    <phone_ext>33</phone_ext>
    <email>clement.foignot@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clément FOIGNOT</last_name>
      <phone>03.80.29.37.72</phone>
      <phone_ext>33</phone_ext>
      <email>clement.foignot@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>July 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2016</study_first_posted>
  <last_update_submitted>August 1, 2016</last_update_submitted>
  <last_update_submitted_qc>August 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

